Carlos Campoy

Insider Reports History

Entity
Individual
Location
11804 North Creek Parkway South, Bothell, WA
Signature
/s/ Daniel Dex, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Carlos Campoy:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CytomX Therapeutics, Inc. Chief Financial Officer Common Stock 38.2K $52.8K $1.38 Mar 16, 2023 Direct
Zymeworks Inc. Director Stock Option (Right to Buy) 37K Dec 7, 2023 Direct
Zymeworks Inc. Director No securities are beneficially owned 0 Jun 30, 2023 Direct

Insider Reports Filed by Carlos Campoy

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ZYME Zymeworks Inc. Dec 7, 2023 1 $0 4 Dec 8, 2023 Director
ZYME Zymeworks Inc. Jun 30, 2023 1 $0 4 Jun 30, 2023 Director
ZYME Zymeworks Inc. Jun 30, 2023 0 $0 3 Jun 30, 2023 Director
CTMX CytomX Therapeutics, Inc. Mar 16, 2023 1 -$3.46K 4 Mar 20, 2023 Chief Financial Officer
CTMX CytomX Therapeutics, Inc. Jul 19, 2022 2 -$5.62K 4 Jul 21, 2022 Chief Financial Officer
CTMX CytomX Therapeutics, Inc. Feb 2, 2022 2 $0 4 Feb 4, 2022 Chief Financial Officer
CTMX CytomX Therapeutics, Inc. Oct 24, 2021 2 $0 4 Oct 26, 2021 Chief Financial Officer
CTMX CytomX Therapeutics, Inc. May 31, 2021 1 $20.2K 4 Jun 8, 2021 Chief Financial Officer